Cornea

SAN FRANCISCO — Stephen Pflugfelder, MD, professor and James and Margaret Elkins Chair in Ophthalmology at Baylor College of Medicine, discussed using topical anti-inflammatory agents to manage atopic and vernal conjunctivitis in a presentation at Cornea Subspecialty Day at the American Academy of Ophthalmology annual meeting.

Investigators found that a thin cornea and low corneal hysteresis have high significance in understanding which patients are at greater risk of glaucoma progression even with well-controlled IOP, according to a recently published study.

SAN FRANCISCO — At the American Academy of Ophthalmology annual meeting, Audrey R. Talley Rostov, MD, cornea, cataract and refractive surgeon at Northwest Eye Surgeons, spoke with Ocular Surgery News about updated medical and surgical treatments for dry eye disease and blepharitis. – by Alaina Tedesco

SAN FRANCISCO — Treatment with low-dose naltrexone resulted in improvements in pain and quality of life scores without serious side effects among patients with neuropathic corneal pain, according to a presenter at the American Academy of Ophthalmology annual meeting.

SAN FRANCISCO — At the Ophthalmology Innovation Summit preceding the American Academy of Ophthalmology annual meeting, Monty Montoya, CEO of CorneaGen, discusses the company’s plans to use the recently announced Series B round of financing to develop Cornea Cell Therapy for treatment of endothelial diseases.

CorneaGen has closed $37 million in Series B financing, according to a press release.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Pavel Stodulka, MD, PhD, speaks about two new concepts in corneal reshaping inlays for presbyopia that have overcome the biocompatibility problems of previous corneal implants. The first, by the biotech company Allotex, is made of corneal donor tissue. The second, by the Swedish company LinkoCare, is made of a bioengineered material similar to human tissue.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Schwind eye-tech-solutions launched the ATOS femtosecond laser, with capabilities for both femtoLASIK and innovative lenticule extraction with the SmartSight technology.

Jack S. Parker, MD, PhD, and colleagues at Parker Cornea in Birmingham, Alabama, demonstrate a surgical technique for implantation of CorneaGen’s Intacs segments for treatment of moderate keratoconus.

PARIS — At the European Society of Cataract and Refractive Surgeons meeting, Emilio Torres-Netto, MD, speaks about a new laser ablation profile that reduces the inflammatory response after PRK, based on preclinical experiments and genetic analyses to see how different ablation profiles affect corneal tissue. This research earned a best poster presentation award at the meeting.